Display options
Cite
NeSmith M, Ahn J, Flamm SL. Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy. Gastroenterol Hepatol (N Y). 2016;12(2):91-100
NeSmith, M., Ahn, J., & Flamm, S. L. (2016). Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy. Gastroenterology & hepatology, 12(2), 91-100.
NeSmith, Meghan, et al. "Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy." Gastroenterology & hepatology vol. 12,2 (2016): 91-100.
NeSmith M, Ahn J, Flamm SL. Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy. Gastroenterol Hepatol (N Y). 2016 Feb;12(2):91-100. PMID: 27182210; PMCID: PMC4865778.
Copy Download .nbib Format: NLM
Share it on

Gastroenterol Hepatol (N Y). 2016 Feb;12(2):91-100.

Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.

Gastroenterology & hepatology

Meghan NeSmith, Joseph Ahn, Steven L Flamm

Affiliations

  1. Dr NeSmith is a gastroenterology fellow and Dr Ahn is an associate professor of medicine and director of clinical hepatology at Oregon Health & Science University in Portland, Oregon. Dr Flamm is a professor of medicine and chief of the liver transplantation program at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

PMID: 27182210 PMCID: PMC4865778

Abstract

Hepatic encephalopathy (HE) is a major complication of liver disease that leads to significant morbidity and mortality. Caring for hospitalized patients with HE is becoming more complex, and the economic burden of HE continues to rise. Defining and diagnosing HE, particularly covert HE (CHE), remain challenging. In this article, we review new tools and those currently under development for the diagnosis of CHE and the latest advances in the acute and long-term management of overt HE (OHE) and CHE. In particular, we review the latest data on the use of lactulose and rifaximin for treatment of OHE and summarize the data on adjunctive agents such as sodium benzoate and probiotics.

Keywords: Hepatic encephalopathy; covert hepatic encephalopathy; lactulose; overt hepatic encephalopathy; rifaximin

References

  1. Cochrane Database Syst Rev. 2004;(2):CD002798 - PubMed
  2. Am J Gastroenterol. 2001 Sep;96(9):2718-23 - PubMed
  3. Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008716 - PubMed
  4. Am J Gastroenterol. 2009 Jun;104(6):1392-400 - PubMed
  5. J Hepatol. 2003 Jan;38(1):51-8 - PubMed
  6. Gastroenterology. 2014 Apr;146(4):961-9 - PubMed
  7. Gastroenterology. 2009 Sep;137(3):885-91, 891.e1 - PubMed
  8. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1384-1389.e2 - PubMed
  9. Clin Liver Dis. 2012 Feb;16(1):43-55 - PubMed
  10. Gastroenterology. 2011 Nov;141(5):1680-9.e1-2 - PubMed
  11. Hepatology. 2002 Mar;35(3):716-21 - PubMed
  12. Liver Int. 2009 May;29(5):629-35 - PubMed
  13. Metab Brain Dis. 2013 Jun;28(2):227-9 - PubMed
  14. Am J Gastroenterol. 2012 Jul;107(7):1043-50 - PubMed
  15. Am J Med. 2003 Feb 15;114(3):188-93 - PubMed
  16. Can J Gastroenterol. 2013 Oct;27(10):572-4 - PubMed
  17. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1390-7.e2 - PubMed
  18. Aliment Pharmacol Ther. 2011 Apr;33(7):739-47 - PubMed
  19. Aliment Pharmacol Ther. 2013 Mar;37(5):527-36 - PubMed
  20. J Gastroenterol Hepatol. 2012 Aug;27(8):1329-35 - PubMed
  21. J Investig Med. 2013 Apr;61(4):695-700 - PubMed
  22. Hepatology. 2014 Aug;60(2):715-35 - PubMed
  23. Am J Gastroenterol. 2011 Sep;106(9):1646-53 - PubMed
  24. Liver Transpl. 2007 Oct;13(10):1366-71 - PubMed
  25. Gastroenterology. 2011 Feb;140(2):478-487.e1 - PubMed
  26. World J Gastroenterol. 2012 Feb 28;18(8):767-77 - PubMed
  27. Hepatol Res. 2012 Oct;42(10):1008-15 - PubMed
  28. Am J Gastroenterol. 2001 Jul;96(7):1968-76 - PubMed
  29. N Engl J Med. 2010 Mar 25;362(12):1071-81 - PubMed
  30. Am J Gastroenterol. 2013 Sep;108(9):1458-63 - PubMed
  31. Hepatology. 2013 Jun;57(6):2448-57 - PubMed
  32. BMJ. 2004 May 1;328(7447):1046 - PubMed
  33. Clin Gastroenterol Hepatol. 2012 Sep;10(9):1034-41.e1 - PubMed
  34. J Gastroenterol Hepatol. 2013 May;28(5):783-92 - PubMed
  35. Cochrane Database Syst Rev. 2003;(2):CD001939 - PubMed
  36. Hepatol Res. 2014 Sep;44(9):956-63 - PubMed
  37. Hepatology. 2013 Sep;58(3):1122-32 - PubMed
  38. J Hepatol. 2006 Jan;44(1):217-31 - PubMed
  39. Aliment Pharmacol Ther. 2010 Nov;32(9):1080-90 - PubMed
  40. Hepatology. 2013 Jul;58(1):325-36 - PubMed
  41. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003047 - PubMed
  42. Hepatology. 2009 Dec;50(6):2014-21 - PubMed
  43. Gastroenterol Hepatol (N Y). 2013 Apr;9(4):219-27 - PubMed
  44. J Hepatol. 1999 May;30(5):890-5 - PubMed
  45. J Hepatol. 2003 Apr;38(4):441-6 - PubMed
  46. Hepatology. 2014 Mar;59(3):1073-83 - PubMed
  47. Clin Nutr. 2014 Dec;33(6):958-65 - PubMed

Publication Types